Search clinical trials for: aspirin, clopidogrel, peptic ulcer, proton pump inhibitor, rabeprazole, ulcer bleeding

Total 10757 results

Takeda

Completed

A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease
Takeda

Completed

The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux

Gastroesophageal Reflux Disease

Poland, United States
Takeda

Completed

A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin

Osteoarthritis | Peptic Ulcer
AstraZeneca

Completed

Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer

Gastric Ulcer

China, Hong Kong
AstraZeneca

Completed

Reflux Esophagitis Phase III Study (Maintenance Treatment)

Reflux Esophagitis

Japan
Taipei Veterans General Hospital, Taiwan

Unknown

Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor

Peptic Ulcer | Ulcer Complications

Taiwan
AstraZeneca

Completed

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Osteoarthritis | Rheumatoid Arthritis | Lumbago | Gastric Ulcer | Duodenal Ulcer

Japan
Wyeth is now a wholly owned subsidiary of Pfizer
Nycomed

Completed

Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux

United States, Canada
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Gastroesophageal Reflux Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux

Belgium, Italy, United States, Australia, Canada, France, Germany, Netherlands, Poland, South Africa, Switzerland
PriCara, Unit of Ortho-McNeil, Inc.
Eisai Inc.

Completed

A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn

Gastroesophageal Reflux
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux | Heartburn
Livzon Pharmaceutical Group Inc.

Unknown

Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

Gastroesophageal Reflux Disease
Chinese University of Hong Kong

Completed

Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

Gastroesophageal Reflux Disease

China
Eisai Inc.

Completed

Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole

Gastroesophageal Reflux Disease

United States
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

Duodenal Ulcer

China
Livzon Pharmaceutical Group Inc.

Completed

Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

Duodenal Ulcer

China
Kaohsiung Medical University Chung-Ho Memorial...
Kaohsiung Medical University

Unknown

Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding

Nonvariceal Upper Gastrointestinal Bleeding

Taiwan
Korean College of Helicobacter and Upper Gastrointestinal...

Unknown

H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection

Ulcer

Korea, Republic of
AstraZeneca

Completed

A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

NSAID Associated Gastric Ulcers
AstraZeneca

Completed

NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

Gastroesophageal Reflux Disease | Erosive Esophagitis | Reflux Esophagitis

United States
AstraZeneca

Completed

Prevention of Gastric Ulcers

NSAID Associated Gastric Ulcers
AstraZeneca

Completed

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

Gastrointestinal Hemorrhage

China
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)
AstraZeneca

Completed

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

Symptomatic Gastroesophageal Reflux Disease (sGERD)
National Taiwan University Hospital
National Science Council, Taiwan

Completed

Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection

Helicobacter Pylori Infection | Duodenal Ulcer

Taiwan
Cogentus Pharmaceuticals

Terminated

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) (COGENT-1)

Myocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Percutaneous Coronary Intervention

United States, France, Canada, Australia, Poland, Germany, Italy, Mexico, Romania, Slovakia, Hungary, Czech Republic, Chile, Bulgaria, Puerto Rico, Ukraine
POZEN

Completed

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

Osteoarthritis | Rheumatoid Arthritis | Ankylosing Spondylitis

United States
Novartis

Completed

Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
Novartis

Completed

Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).

Gastroesophageal Reflux Disease (GERD)

United States
University of Cincinnati
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea

Obstructive Sleep Apnea | Acid Reflux Disease

United States
Pamela Youde Nethersole Eastern Hospital

Unknown

Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer (NPH)

Peptic Ulcer

China
Chinese University of Hong Kong

Completed

Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib

Arthritis | Bleeding Ulcer

China
Hamamatsu University
Yokoyama Foundation for Clinical Pharmacology

Unknown

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Gastritis | Helicobacter Infections | Gastric Ulcer | Duodenal Ulcer

Japan
Hamamatsu University

Unknown

Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection

Gastritis | Helicobacter Infections | Gastric Ulcer | Duodenal Ulcer

Japan
UMC Utrecht
Takeda

Unknown

On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication

Peptic Ulcer | GERD | GORD | Reflux | Chronic Use of Acid Suppressive Medication
National Taiwan University Hospital

Unknown

The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

Peptic Ulcer With H. Pylori Infection | Gastritis With H. Pylori Infection

Taiwan
Boehringer Ingelheim

Recruiting

A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

Healthy

Germany
Celgene

Not yet recruiting

Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

Healthy Participants

United States
Eilean Therapeutics

Recruiting

Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers

AML

Australia
Mahidol University

Recruiting

Hemostatic Forceps vs. Bipolar Electrocautery Probes for High-Risk Bleeding Gastroduodenal Ulcers

Gastroduodenal Ulcer

Thailand
Murdoch Childrens Research Institute

Not yet recruiting

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. (PEGASUS)

Hodgkin Lymphoma | Non Hodgkin Lymphoma

Australia
Seoul National University Bundang Hospital

Recruiting

Tegoprazan-containing Sequential for H. Pylori

Helicobacter Pylori Infection

Korea, Republic of
Bayer

Recruiting

A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

Healthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation

United States
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

Colorectal Neoplasia

United States
Cerevel Therapeutics, LLC

Not yet recruiting

A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants

Healthy Participants
Kaohsiung Medical University

Recruiting

Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication

Helicobacter Pylori Eradication

Taiwan
Abbisko Therapeutics Co, Ltd

Not yet recruiting

A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021

Healthy Subjects
Hospital General de México Dr. Eduardo Liceaga

Not yet recruiting

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

Helicobacter Pylori Infection

3

Subscribe